JP2001503630A5 - - Google Patents

Download PDF

Info

Publication number
JP2001503630A5
JP2001503630A5 JP1998521812A JP52181298A JP2001503630A5 JP 2001503630 A5 JP2001503630 A5 JP 2001503630A5 JP 1998521812 A JP1998521812 A JP 1998521812A JP 52181298 A JP52181298 A JP 52181298A JP 2001503630 A5 JP2001503630 A5 JP 2001503630A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998521812A
Other languages
English (en)
Japanese (ja)
Other versions
JP4102445B2 (ja
JP2001503630A (ja
Filing date
Publication date
Priority claimed from US08/743,168 external-priority patent/US6271015B1/en
Application filed filed Critical
Publication of JP2001503630A publication Critical patent/JP2001503630A/ja
Publication of JP2001503630A5 publication Critical patent/JP2001503630A5/ja
Application granted granted Critical
Publication of JP4102445B2 publication Critical patent/JP4102445B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP52181298A 1996-11-04 1997-11-04 脂肪酸アミドヒドロラーゼ Expired - Lifetime JP4102445B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/743,168 1996-11-04
US08/743,168 US6271015B1 (en) 1995-06-12 1996-11-04 Fatty-acid amide hydrolase
PCT/US1997/020385 WO1998020119A1 (en) 1996-11-04 1997-11-04 Fatty-acid amide hydrolase

Publications (3)

Publication Number Publication Date
JP2001503630A JP2001503630A (ja) 2001-03-21
JP2001503630A5 true JP2001503630A5 (https=) 2005-07-14
JP4102445B2 JP4102445B2 (ja) 2008-06-18

Family

ID=24987760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52181298A Expired - Lifetime JP4102445B2 (ja) 1996-11-04 1997-11-04 脂肪酸アミドヒドロラーゼ

Country Status (10)

Country Link
US (3) US6271015B1 (https=)
EP (1) EP0970195B1 (https=)
JP (1) JP4102445B2 (https=)
AT (1) ATE376055T1 (https=)
AU (1) AU739962B2 (https=)
CA (1) CA2270293A1 (https=)
DE (1) DE69738221T2 (https=)
DK (1) DK0970195T3 (https=)
ES (1) ES2294802T3 (https=)
WO (1) WO1998020119A1 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE443526T1 (de) * 1999-08-20 2009-10-15 Takeda Pharmaceutical Zusammensetzung für perkutane absorption mit einem melantoninrezeptor-agonistisch wirkendem wirkstoff
IL158131A0 (en) 2001-03-27 2004-03-28 Univ California Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
US20050054730A1 (en) * 2001-03-27 2005-03-10 The Regents Of The University Of California Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
CA2442330A1 (en) * 2001-03-29 2002-10-10 Emory University Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
US9493805B2 (en) * 2001-06-01 2016-11-15 Colorado State University Research Foundation Enzymatic biosensors with enhanced activity retention for detection of organic compounds
US8323956B2 (en) * 2001-06-01 2012-12-04 Colorado State University Research Foundation Distal tip of biosensor transducer comprising enzyme for deamination
US9493806B2 (en) 2001-06-01 2016-11-15 Colorado State University Research Foundation Enzymatic biosensing systems
EA010267B1 (ru) * 2002-10-07 2008-06-30 Те Риджентс Оф Те Юниверсити Оф Калифорния Модуляция тревоги через блокаду гидролиза анандамида
US7765162B2 (en) * 2002-10-07 2010-07-27 Mastercard International Incorporated Method and system for conducting off-line and on-line pre-authorized payment transactions
JP2006516095A (ja) * 2002-11-14 2006-06-22 ザ スクリップス リサーチ インスティテュート 脂肪酸アミドヒドロラーゼ(faah)の結晶形
JP2007509066A (ja) * 2003-10-16 2007-04-12 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 体脂肪を減らし、食欲を抑制し、脂肪酸代謝を調節するための食物および他の組成物、化合物ならびに方法
US8086315B2 (en) 2004-02-12 2011-12-27 Asap Medical, Inc. Cardiac stimulation apparatus and method for the control of hypertension
US20060084659A1 (en) * 2004-10-19 2006-04-20 Michael Davis Augmentation of psychotherapy with cannabinoid reuptake inhibitors
WO2006067613A1 (en) * 2004-12-22 2006-06-29 Warner-Lambert Company Llc Compositions and methods for expression and purification of fatty acid amide hydrolase
JP2010505868A (ja) * 2006-10-02 2010-02-25 ザ スクリプス リサーチ インスティチュート エーテル脂質シグナル伝達経路を制御する酵素
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
DE602007011793D1 (de) * 2006-10-18 2011-02-17 Pfizer Prod Inc Biaryl-ether-harnstoffverbindungen
US9796998B2 (en) 2007-04-09 2017-10-24 Colorado State University Research Foundation Oxygenase-based biosensing systems for measurement of halogenated alkene concentrations
CA2702468A1 (en) 2007-10-12 2009-04-23 University Of Connecticut Therapeutic applications of fatty acid amide hydrolase inhibitors
CA2721060A1 (en) * 2008-04-09 2009-10-15 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118155A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US9062116B2 (en) 2009-04-23 2015-06-23 Infinity Pharmaceuticals, Inc. Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
RU2015143910A (ru) 2010-02-03 2018-12-28 Инфинити Фармасьютикалз, Инк. Ингибиторы амид-гидролазы жирных кислот
JP2013147430A (ja) * 2010-04-28 2013-08-01 Astellas Pharma Inc 夜間頻尿の予防又は治療剤
TW201206440A (en) * 2010-04-28 2012-02-16 Astellas Pharma Inc Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
US9187413B2 (en) 2010-07-28 2015-11-17 The Regents Of The University Of California Peripherally restricted FAAH inhibitors
US10024797B2 (en) 2010-11-22 2018-07-17 Colorado State University Research Foundation Biosensing systems for measurement of lactose
WO2013019982A2 (en) 2011-08-02 2013-02-07 Colorado State University Research Foundation Biosensing system with extended lifetime via cofactor recycling
KR102079404B1 (ko) 2011-08-19 2020-02-19 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 메타-치환된 비페닐 말초 제한형 faah 억제제
EP2931291B1 (en) 2012-12-11 2021-10-20 The McLean Hospital Corporation Xenon treatment as an adjunct to psychotherapy for psychiatric disorders
US9008769B2 (en) 2012-12-21 2015-04-14 Backbeat Medical, Inc. Methods and systems for lowering blood pressure through reduction of ventricle filling
RU2685729C2 (ru) * 2012-12-28 2019-04-23 Ром Энд Хаас Компани Водные дисперсии амидов жирных кислот
MX372678B (es) 2012-12-28 2020-03-25 Rohm & Haas Adhesivos hidrosolubles.
US9370662B2 (en) 2013-12-19 2016-06-21 Backbeat Medical, Inc. Methods and systems for controlling blood pressure by controlling atrial pressure
GB201404468D0 (en) 2014-03-13 2014-04-30 Givaudan Sa Process
ES2908240T3 (es) 2014-04-07 2022-04-28 Univ California Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos
US10342982B2 (en) 2015-09-11 2019-07-09 Backbeat Medical, Inc. Methods and systems for treating cardiac malfunction
EP3362462B1 (en) 2015-10-12 2021-07-21 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
US10485658B2 (en) 2016-04-22 2019-11-26 Backbeat Medical, Inc. Methods and systems for controlling blood pressure
CN111278969A (zh) 2017-09-12 2020-06-12 银杏生物制品公司 保护性酶

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165258A (en) 1975-10-08 1979-08-21 University Of Pennsylvania Plasminogen activating enzyme-specific competitive inhibitor

Similar Documents

Publication Publication Date Title
JP2000513961A5 (https=)
JP2001507533A5 (https=)
JP2000515657A5 (https=)
JP2000501599A5 (https=)
JP2000501018A5 (https=)
JP2001505363A5 (https=)
JP2000501324A5 (https=)
JP2000502472A5 (https=)
JP2000501338A5 (https=)
JP2000500874A5 (https=)
JP2000503989A5 (https=)
JP2000502485A5 (https=)
JP2000502425A5 (https=)
JP2000502568A5 (https=)
JP2001503630A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2001502658A5 (https=)
JP2000515368A5 (https=)
JP2000509294A5 (https=)
JP2000506725A5 (https=)
JP2000501744A5 (https=)
JP2000501229A5 (https=)
JP2000500857A5 (https=)
JP2000502316A5 (https=)